Elsevier

Brain and Development

Volume 32, Issue 9, October 2010, Pages 719-730
Brain and Development

Review article
Autism spectrum disorders and epilepsy: Moving towards a comprehensive approach to treatment

https://doi.org/10.1016/j.braindev.2010.05.007Get rights and content

Abstract

The biological and phenotypic heterogeneity of children with autism spectrum disorders (ASD) and epilepsy presents a significant challenge to the development of effective treatment protocols. There is no single treatment or treatment protocol for children with ASD or epilepsy. Children with co-occurring ASD and epilepsy should undergo a comprehensive assessment that includes investigation of underlying biological etiologies as well assessment of cognitive, language, affective, social and behavioral function prior to initiating treatment. The comprehensive treatment of children with ASD is based on a combination of therapeutic psychosocial interventions in combination with pharmacological agents. A process-oriented approach to assessment and intervention allows careful analysis of the child’s response to treatment such that treatment protocols may be revised secondary to any changes in developmental trajectory of the child with ASD and epilepsy. The possibility of developing pharmacological interventions that target both ASD and epilepsy awaits definitive evidence. The best hope for good developmental outcomes in children with ASD and epilepsy is early recognition and comprehensive treatment of both the ASD and epilepsy.

Introduction

Autism spectrum disorder (ASD) is a broad classification that includes a heterogeneous group of individuals with behaviorally defined impairments in reciprocal social interaction, verbal and non-verbal communication, and restricted and repetitive behaviors. The ASD category includes those with autistic disorder, pervasive developmental disorder not otherwise specified or Asperger syndrome. It excludes two other categories included in the Diagnostic and Statistical Manual of Mental Disorders 4th Edition Text Revision (DSM IV-TR) [1] and the 10th Edition of the International Classification of Diseases (ICD 10), Rett disorder and childhood disintegrative disorder. Epilepsy is another broad diagnostic category and is defined as having more than one seizure. Seizures are the most dramatic aspect of epilepsy although recent definitions of epilepsy have emphasized the neurologic, cognitive, psychological, and social consequences of this group of disorders [2]. Classification systems for seizures [3] and for epilepsy [4] have been developed and are academically useful but how best to classify seizures and define epilepsy remains an evolving and controversial issue [5].

The prevalence of epilepsy in the ASD population is estimated to be approximately 30% although this number is highly variable depending on the study sample [6]. While the prevalence of ASD in children with epilepsy has been studied less, Clark and colleagues [7] found that approximately 30% of children in a tertiary epilepsy clinic met criteria for ASD. Clearly, the association of ASD and epilepsy is higher than one would expect by chance and the co-occurrence of ASD and epilepsy negatively impacts developmental outcomes and quality of life [8].

In children with epilepsy, younger age at seizure onset, cognitive impairment, temporal or frontal lobe onset of seizures, and intractable epilepsy are associated with an increased likelihood of co-existing social-communication and behavioral disorders [9]. In children with ASD, cognitive and motor impairments, severity of receptive language deficits, and genetic and molecular abnormalities are associated with an increased prevalence of epilepsy [10]. In some children with co-occurring ASD and epilepsy there appears to be a common etiology and pathogenesis. However, our understanding of the pathophysiology of co-occurring ASD and epilepsy is still limited. While the ASD and epilepsy categories are useful and practical for classification purposes they are mainly descriptive and do not reflect singular entities with uniform etiologies [11], [12]. It follows that there is no one single treatment or treatment protocol for children with ASD or epilepsy.

How often a common cause accounts for the co-occurrence of ASD and epilepsy is an interesting but as yet unanswered question. The answer to this question and an understanding of the pathogenesis common to both ASD and epilepsy will provide an avenue for novel therapeutics. At present, the known biological and phenotypic heterogeneity of children with ASD–epilepsy phenotypes presents a significant challenge to the development of treatment protocols. Throughout this review of intervention options we highlight therapeutic strategies most likely to improve developmental outcomes for children with ASD and epilepsy.

Section snippets

Children with ASD who develop epilepsy

The aim of treatment in children with epilepsy is to effectively eliminate seizures without compromising cognitive and behavioral functions [13]. This aim applies equally to the treatment of epilepsy in children with an established diagnosis of ASD [14], [15]. Pharmacological interventions for epilepsy that reduce and eliminate seizures have been developed [16] and these medications are effective in reducing or eliminating seizures in children with ASD and epilepsy. As in epilepsy, seizure

Children with epilepsy who develop ASD

In children with epilepsy the highest risk for developing ASD is in those with seizures in the first year of life [80]. Approximately 40% of all epilepsies occurring during the first 3 years of life fit the definition of epileptic encephalopathies [11]. Epileptic encephalopathies are defined as “a condition in which the epileptiform abnormalities themselves are believed to contribute to the progressive disturbance in cerebral function” [81]. The epileptic encephalopathies begin early in life and

Controversies in treatment: regression and epileptiform EEG

There continues to be debate whether epilepsy or the epileptiform EEG could be a causal factor in the development of the ASD phenotype and whether treatment, medical or surgical, can prevent or reverse the cognitive and behavioral manifestations [140]. What we can say is that children with epileptic encephalopathies, especially those with seizures in the first 3 years of life, are at high risk for the development of ASD. What is controversial is whether epileptiform activity can trigger

Conclusions

Advances in our understanding of the molecular biology of ASD and of epilepsy now allow us to conceptualize intervention strategies that may positively change the developmental trajectory of both ASD and epilepsy. An emerging approach to target more specifically the ASD–epilepsy phenotype is based on our understanding that abnormalities of synaptic structure and function are central to the brain basis of ASD [178] and of epilepsy [179]. Translation of basic science and mouse model data will be

References (198)

  • A.B. Ettinger et al.

    Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain

    Neurotherapeutics

    (2007)
  • T.C. Warwick et al.

    Effects of vagus nerve stimulation in a patient with temporal lobe epilepsy and Asperger syndrome: case report and review of the literature

    Epilepsy Behav

    (2007)
  • Y.D. Park

    The effects of vagus nerve stimulation therapy on patients with intractable seizures and either Landau–Kleffner syndrome or autism

    Epilepsy Behav

    (2003)
  • S. Danielsson et al.

    Lack of effects of vagus nerve stimulation on drug-resistant epilepsy in eight pediatric patients with autism spectrum disorders: a prospective 2-year follow-up study

    Epilepsy Behav

    (2008)
  • J.G. Mantis et al.

    Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets

    Epilepsy Behav

    (2009)
  • W.F. Arts et al.

    When to start drug treatment for childhood epilepsy: the clinical–epidemiological evidence

    Eur J Paediatr Neurol

    (2009)
  • L. Kayaalp et al.

    EEG abnormalities in West syndrome: correlation with the emergence of autistic features

    Brain Dev

    (2007)
  • APA. Diagnostic and statistical manual of mental disorders (DSM-IV-TR). 4th, text rev. DSM-IV-TR ed. Washington, DC:...
  • R.S. Fisher et al.

    Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

    Epilepsia

    (2005)
  • ILAE. ILAE commission on classification and terminology of the international league against epilepsy: proposal for...
  • ILAE. ILAE proposal for revised classification of epilepsies and epileptic syndromes. Commission on classification and...
  • E.H. Reynolds et al.

    The clinical concept of epilepsy

    Epilepsia

    (2009)
  • S.J. Spence et al.

    The role of epilepsy and epileptiform EEGs in autism spectrum disorders

    Pediatr Res

    (2009)
  • D.F. Clarke et al.

    The prevalence of autistic spectrum disorder in children surveyed in a tertiary care epilepsy clinic

    Epilepsia

    (2005)
  • S. Danielsson et al.

    Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood

    Epilepsia

    (2005)
  • L.D. Hamiwka et al.

    Comorbidities in pediatric epilepsy: beyond “Just” treating the seizures

    J Child Neurol

    (2009)
  • F. Happe et al.

    Time to give up on a single explanation for autism

    Nat Neurosci

    (2006)
  • R. Guerrini et al.

    Practitioner review: use of antiepileptic drugs in children

    J Child Psychol Psychiatry

    (2006)
  • C. Gillberg

    The treatment of epilepsy in autism

    J Autism Dev Disord

    (1991)
  • S.D. Shorvon

    Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959–2009

    Epilepsia

    (2009)
  • J.K. Austin et al.

    Behavioral and psychiatric comorbidities in pediatric epilepsy: toward an integrative model

    Epilepsia

    (2007)
  • F.M. Besag

    Behavioral aspects of pediatric epilepsy syndromes

    Epilepsy Behav

    (2004)
  • R. Caplan et al.

    Behavioral aspects of epilepsy in children with mental retardation

    Ment Retard Dev Disabil Res Rev

    (2000)
  • N. Zecavati et al.

    Neurometabolic disorders and dysfunction in autism spectrum disorders

    Curr Neurol Neurosci Rep

    (2009)
  • B.A. Malow et al.

    Characterizing sleep in children with autism spectrum disorders: a multidimensional approach

    Sleep

    (2006)
  • H. Allik et al.

    Sleep patterns of school-age children with Asperger syndrome or high-functioning autism

    J Autism Dev Disord

    (2006)
  • N.M. Oyane et al.

    Sleep disturbances in adolescents and young adults with autism and Asperger syndrome

    Autism

    (2005)
  • A.L. Richdale

    Sleep problems in autism: prevalence, cause, and intervention

    Dev Med Child Neurol

    (1999)
  • M. Xue et al.

    Autism spectrum disorders: concurrent clinical disorders

    J Child Neurol

    (2008)
  • J.J. Garcia-Penas

    Autism, epilepsy and mitochondrial disease: points of contact

    Rev Neurol

    (2008)
  • J.R. Weissman et al.

    Mitochondrial disease in autism spectrum disorder patients: a cohort analysis

    PLoS ONE

    (2008)
  • Y.M. Lee et al.

    Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions

    Epilepsia

    (2008)
  • M. Mintz et al.

    Treatment approaches for the autism spectrum disorders

  • R.L. Findling

    Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders

    J Clin Psychiatry

    (2005)
  • R. Tuchman

    AEDs and psychotropic drugs in children with autism and epilepsy

    Ment Retard Dev Disabil Res Rev

    (2004)
  • J.K. Buitelaar

    Why have drug treatments been so disappointing?

    Novartis Found Symp

    (2003)
  • F.R. Volkmar

    Pharmacological interventions in autism: theoretical and practical issues

    J Clin Child Psychol

    (2001)
  • M.S. Parikh et al.

    Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

    J Child Adolesc Psychopharmacol

    (2008)
  • C.J. McDougle et al.

    Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology

    Am J Psychiatry

    (2005)
  • P. Howlin

    Identifying effective interventions for young children with autism spectrum disorders

    J Intellect Disabil Res

    (2008)
  • Cited by (0)

    View full text